Redeye comments on SciBase announcing a newly published study evaluating the use of Nevisense for assessing skin barrier impairment. The findings further support the robustness and scientific relevance of the technology, strengthening our view that the ongoing studies with Kenvue and Castle Biosciences are well-positioned to deliver encouraging results.
LÄS MER
